Bottom line
ECHSX vs JDOC: the short answer
ECHSX (Eaton Vance Worldwide Health Sciences Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
JDOC is cheaper at 0.65% vs 1.93% — a difference of $128 a year per $10,000 invested.
Over one year, JDOC returned +14.9% vs +1.7% for ECHSX (reporting dates differ).
Updated Nov 19, 2026
ECHSX vs JDOC side by side
| ECHSX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.93% | 0.65% |
| Annual cost per $10k | $193 | $65 |
| 10-yr cost on $10k (prospectus) | $2,089 | $810 |
| Max front load | 0% | None |
| 12b-1 fee | 1% | — |
| 1-yr return | +1.7% | +14.9% |
| 5-yr return (annualized) | +5.6% | — |
| 10-yr return (annualized) | +6.3% | — |
| Best quarter | — | +11.3% |
| Worst quarter | — | −11.9% |
| Net assets (fund) | $757.9M | $9.1M |
| Number of holdings | 42 | 61 |
| Portfolio turnover | 3% | 92% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of ECHSX's top 25 holdings also appear in JDOC's top 25.
| Holding | ECHSX | JDOC |
|---|---|---|
| Eli Lilly & Co | 12.47% | 7.76% |
| AbbVie Inc | 6.46% | 7.85% |
| Johnson & Johnson | 6.45% | 4.82% |
| AstraZeneca PLC | 6.24% | 3.76% |
| UnitedHealth Group Inc | 5.49% | 5.85% |
| Roche Holding AG | 5.44% | 2.82% |
| Merck & Co Inc | 5.08% | 4.82% |
| Bristol-Myers Squibb Co | 4.25% | 3.57% |
| Thermo Fisher Scientific Inc | 2.79% | 3.73% |
| Intuitive Surgical Inc | 2.72% | 1.93% |
| Stryker Corp | 2.21% | 2.23% |
| Novo Nordisk A/S | 1.71% | 2.61% |
| Abbott Laboratories | 1.65% | 3.11% |
| Novartis AG | 1.65% | 1.60% |
Source: SEC Form N-PORT
ECHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between ECHSX and JDOC?
ECHSX (Eaton Vance Worldwide Health Sciences Fund) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds. JDOC is cheaper at 0.65% vs 1.93% — a difference of $128 a year per $10,000 invested.
Which is cheaper, ECHSX or JDOC?
JDOC has the lower expense ratio (0.65%).
Should I own both ECHSX and JDOC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.